Outcomes of transition from selexipag to parenteral prostacyclin analogues in patients with pulmonary arterial hypertension.

AlEissa E, Kolkman L, Kapasi A, Peng D, Provencher S, Brunner N, Swiston J

DOI: 10.1183/23120541.00131-2026
Published: 2026 Sep
Container: ERJ open research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1183/23120541.00131-2026,
  title = {Outcomes of transition from selexipag to parenteral prostacyclin analogues in patients with pulmonary arterial hypertension.},
  author = {AlEissa E and Kolkman L and Kapasi A and Peng D and Provencher S and Brunner N and Swiston J},
  year = {2026},
  journal = {ERJ open research},
  doi = {10.1183/23120541.00131-2026},
  url = {https://doi.org/10.1183/23120541.00131-2026}
}

RIS

TY  - JOUR
TI  - Outcomes of transition from selexipag to parenteral prostacyclin analogues in patients with pulmonary arterial hypertension.
AU  - AlEissa E
AU  - Kolkman L
AU  - Kapasi A
AU  - Peng D
AU  - Provencher S
AU  - Brunner N
AU  - Swiston J
PY  - 2026
JO  - ERJ open research
DO  - 10.1183/23120541.00131-2026
UR  - https://doi.org/10.1183/23120541.00131-2026
ER  -

APA

E, A., L, K., A, K., D, P., S, P., N, B., & J, S. (2026). Outcomes of transition from selexipag to parenteral prostacyclin analogues in patients with pulmonary arterial hypertension.. ERJ open research. https://doi.org/10.1183/23120541.00131-2026

Source records

pubmed · retrieved 2026-09-26T13:53:22.915Z